Mesothelioma is an aggressive cancer that arises from the mesothelium, the thin layer of cells that lines the lungs (pleura), abdomen (peritoneum), heart (pericardium), or testicles (tunica vaginalis). The pleural form is the most common. The overwhelming majority of cases are caused by inhaled or swallowed asbestos fibers, often decades before the cancer appears.
Origin
The term combines the Greek roots mesos (middle) and thēlē (referring here to the epithelial lining), with the suffix -oma (tumor). The disease was first clearly linked to asbestos exposure in J.C. Wagner's landmark 1960 study of crocidolite miners in South Africa's Northwestern Cape Province.
Significance in Asbestos Context
Mesothelioma is considered a "signal" or "sentinel" cancer for asbestos exposure, meaning a diagnosis strongly implies prior asbestos exposure even when the patient can't remember it. This makes it one of the most legally and medically distinctive asbestos diseases: courts, trust funds, and the VA generally accept the asbestos-mesothelioma link without requiring extensive proof of disease causation, so the central questions in a case usually become which products, which jobsites, and which defendants caused the exposure. Histologic subtype (epithelioid, sarcomatoid, biphasic), tumor location, and stage all affect prognosis, treatment options, and the value of a claim, so accurate pathology, often including a second opinion at a mesothelioma center, is critical.
Example Sentence
After months of shortness of breath and a pleural effusion that kept returning, the biopsy confirmed epithelioid pleural mesothelioma, and her oncologist began asking detailed questions about her late husband's work at the shipyard.
Related Terms
Pleural Mesothelioma, Peritoneal Mesothelioma, Epithelioid Mesothelioma, Sarcomatoid Mesothelioma, Latency Period, Asbestos Exposure, Helsinki Criteria
Notes
- Ask whether your pathology slides have been reviewed by a mesothelioma specialty center (such as an NCI-designated cancer center); subtype and confirmation directly affect treatment options and case strength.
- Begin a detailed exposure history immediately. List every job, military assignment, home renovation, and household member's occupation going back 20–60 years; memories fade fast and this document becomes central evidence.
- Preserve all imaging (CT, PET), pathology reports, immunohistochemistry results, and operative notes; defendants and trust funds will request these and missing records can delay compensation.
- Ask your oncologist about clinical trials and multimodal treatment (surgery, chemotherapy, immunotherapy, radiation). Eligibility often depends on subtype and stage at diagnosis.
- If you are a U.S. veteran, mesothelioma is a recognized service-connected condition for many exposure scenarios; a VA claim can proceed in parallel with civil litigation and asbestos trust claims.
In the research library
6,103 studies in our medical research library mention Mesothelioma in the title or abstract. Among the most cited:
- Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trialG. Zalcman, J. Mazieres, J. Margery, et al, 2016 · Lancet · cited 762 times
- The European mesothelioma epidemicJ. Peto, A. Decarli, C. La Vecchia, et al, 1999 · British Journal of Cancer · cited 691 times
- Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain TumorsS. Hendry, R. Salgado, T. Gevaert, et al, 2017 · Advances in Anatomic Pathology · cited 657 times
- Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesotheliomaK. Donaldson, F.A. Murphy, R. Duffin, et al, 2010 · Particle and Fibre Toxicology · cited 606 times
- Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility studyT. Treasure, L. Lang-Lazdunski, D. Waller, et al, 2011 · The Lancet. Oncology · cited 527 times
The journals that publish most on it: American Journal of Industrial Medicine (177), British Journal of Cancer (117), Lung Cancer (115).
Category: Diseases & Conditions · All Lexicon terms A–Z
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.